AstraZeneca Pharmaceuticals LP
FDA inspection history in Wilmington, Delaware, 2023
- 1
- Warning letter
- 1
- Close-out
Every document, by year
- Warning letter
- Close-out
2023: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One warning letter, at Wilmington, Delaware.
The complete AstraZeneca Pharmaceuticals file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
$198
The price of the documents, added to your cart together
Sites
Wilmington, Delaware
One warning letter and one close-out letter · 2023
Latest: Warning letter, Aug 4, 2023 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-08-04 | Warning letter Warning letter | Wilmington, Delaware | — | $99 |
| Undated | Close-out Close-out letter | Wilmington, Delaware | — | $99 |
FEI number 2518137 · most recent document Aug 4, 2023
About AstraZeneca Pharmaceuticals LP
Has AstraZeneca Pharmaceuticals LP received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for AstraZeneca Pharmaceuticals LP; the most recent is dated Aug 4, 2023.